TY - JOUR AU - Berk, Michael AU - Dean, Olivia M. AU - Cotton, Sue M. AU - Gama, Clarissa S. AU - Kapczinski, Flavio AU - Fernandes, Brisa AU - Kohlmann, Kristy AU - Jeavons, Susan AU - Hewitt, Karen AU - Moss, Kirsteen AU - Allwang, Christine AU - Schapkaitz, Ian AU - Cobb, Heidi AU - Bush, Ashley I. AU - Dodd, Seetal AU - Malhi, Gin S. PY - 2012 DA - 2012/08/14 TI - Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial JO - BMC Medicine SP - 91 VL - 10 IS - 1 AB - N-acetyl cysteine (NAC) is a glutathione precursor that has been shown to have antidepressant efficacy in a placebo-controlled trial. The current study aimed to investigate the maintenance effects of NAC following eight weeks of open-label treatment for bipolar disorder. SN - 1741-7015 UR - https://doi.org/10.1186/1741-7015-10-91 DO - 10.1186/1741-7015-10-91 ID - Berk2012 ER -